Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Paola Martelli

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Haematologica|July 3, 2009
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapyBrunangelo Falini, Maria Paola Martelli
Best Practice & Research. Clinical Haematology|November 23, 2015
Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
American Journal of Hematology|January 6, 2023
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
Blood|September 17, 2011
NPM1-mutated AML: targeting by disassemblingBrunangelo Falini, Maria Paola Martelli
Blood|August 25, 2016
BRAF V600E mutation in hairy cell leukemia: from bench to bedsideBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci
American Journal of Hematology|January 25, 2023
Mutant NPM1: Nuclear export and the mechanism of leukemogenesisBrunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti
Current Opinion in Oncology|September 23, 2009
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectivesBrunangelo Falini, Paolo Sportoletti, Maria Paola Martelli
Blood|November 10, 2020
How I diagnose and treat NPM1-mutated AMLBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
The New England Journal of Medicine|September 17, 2015
Dactinomycin in NPM1-Mutated Acute Myeloid LeukemiaBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
Blood|July 2, 2020
NPM1-mutated acute myeloid leukemia: from bench to bedsideBrunangelo Falini, Lorenzo Brunetti, Paolo Sportoletti, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Haematologica|July 3, 2009
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapyBrunangelo Falini, Maria Paola Martelli
Best Practice & Research. Clinical Haematology|November 23, 2015
Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
American Journal of Hematology|January 6, 2023
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
Blood|September 17, 2011
NPM1-mutated AML: targeting by disassemblingBrunangelo Falini, Maria Paola Martelli
Blood|August 25, 2016
BRAF V600E mutation in hairy cell leukemia: from bench to bedsideBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci
American Journal of Hematology|January 25, 2023
Mutant NPM1: Nuclear export and the mechanism of leukemogenesisBrunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti
Current Opinion in Oncology|September 23, 2009
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectivesBrunangelo Falini, Paolo Sportoletti, Maria Paola Martelli
Blood|November 10, 2020
How I diagnose and treat NPM1-mutated AMLBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
The New England Journal of Medicine|September 17, 2015
Dactinomycin in NPM1-Mutated Acute Myeloid LeukemiaBrunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
Blood|July 2, 2020
NPM1-mutated acute myeloid leukemia: from bench to bedsideBrunangelo Falini, Lorenzo Brunetti, Paolo Sportoletti, et al.
Pageof 13